Semi-Annual Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7302029

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
3,825,000,000 JPY
-4,000,000 JPY
177,000,000 JPY
3,345,000,000 JPY
3,998,000,000 JPY
-652,000,000 JPY
44,000,000 JPY
3,641,000,000 JPY
3,658,000,000 JPY
3,055,000,000 JPY
-585,000,000 JPY
-61,000,000 JPY
Non-operating income
Non-operating income
204,000,000 JPY
224,000,000 JPY
Non-operating expenses
Non-operating expenses
238,000,000 JPY
183,000,000 JPY
Ordinary profit (loss)
3,312,000,000 JPY
3,096,000,000 JPY
Extraordinary income
Extraordinary income
JPY
2,314,000,000 JPY
Profit (loss) before income taxes
3,312,000,000 JPY
5,410,000,000 JPY
Income taxes - current
602,000,000 JPY
1,424,000,000 JPY
Income taxes - deferred
150,000,000 JPY
-143,000,000 JPY
Profit (loss)
2,560,000,000 JPY
4,129,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.